ORGARAN DIN 02129043
Health Canada record
| Active ingredient(s) | DANAPAROID SODIUM 750 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AB09 DANAPAROID |
| Original market date | 31-Dec-1995 |
| Current status date | 06-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Aspen Pharmacare Canada Inc. — licence 3-002349, currently licensed, last inspection rating C (2026-03-12).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20466 | 2018-02-09 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 17219 | 2015-08-24 | New Drug Submission (NDS) | TRANSFER OF DIN OWNERSHIP |
| 12267 | 2011-04-14 | New Drug Submission (NDS) | Manufacturer name change |
| 10913 | 2010-01-12 | New Drug Submission (NDS) | Manufacturer name change |
| 5813 | 1994-10-05 | New Drug Submission (NDS) |
International API supply for DANAPAROID SODIUM
0 active FDA Drug Master Files.
Request a quote for ORGARAN